GlassScriptPhysician profile
Ali Jamal Noory
NPI 1528597036
$10,908.12
in general payments reported to CMS, 2019-2025
19 companies · $7,036 in 2025
The $7,036 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $780 · 2022: $232 · 2023: $1,984 · 2024: $876 · 2025: $7,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,614 · Travel and Lodging: $3,508 · Education: $774.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,613.58 |
| Travel and Lodging | $3,508.33 |
| Education | $773.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $4,167.49 | 2025 | General - Therapies, Farapulse, Accolade Sr |
| Abbott Laboratories | $3,652.21 | 2021-2025 | Ensite, Gallant, Ensite Precision |
| Biosense Webster, INC. | $767.51 | 2024-2025 | Carto 3 |
| Abiomed | $327.49 | 2021-2025 | Impella |
| Medtronic, INC. | $320.27 | 2025 | Micra, Affera Mapping System, Cobalt Dr Mri Surescan |
| Acist Medical Systems, INC. | $227.15 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $226.57 | 2021-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $205.23 | 2021-2023 | Lifevest |
| Inari Medical, INC. | $153.26 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Impulse Dynamics (USA) INC. | $148.03 | 2023 | Optimizer |
| Amgen INC. | $143.43 | 2022-2023 | Repatha |
| W. L. Gore & Associates, INC. | $124.99 | 2021 | |
| Astellas Pharma US INC | $118.00 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $96.64 | 2022 | |
| Lantheus Medical Imaging, INC. | $76.32 | 2023 | Definity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kiniksa Pharmaceuticals, LTD. | $71.03 | 2023 | Arcalyst |
| Edwards Lifesciences Corporation | $48.97 | 2025 | |
| Terumo Medical Corporation | $19.24 | 2025 | Glidesheath Slender, Heartrail, Metacross Otw |
| Ancora Heart, INC. | $14.29 | 2023 | Accucinch |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ali Noory listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.